Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-labelRandomized Trial

Authors

Fengchun Wu (ORCID: https://orcid.org/0000-0003-2817-2341)
Min Xiu (ORCID: https://orcid.org/0009-0004-6329-2570)
Xiaoni Guan

Institutions

Peking University (CN)
Beijing HuiLongGuan Hospital (CN)
Guangzhou Medical University (CN)

Publication Details

Journal: Current Neuropharmacology
Published: 2025-11-03
DOI: https://doi.org/10.2174/011570159x395131251008050155
Primary Topic: Schizophrenia research and treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-labelRandomized Trial

Fengchun Wu, Min Xiu, Xiaoni Guan

Nov 3, 2025

Current Neuropharmacology

Schizophrenia research and treatment

article

Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-labelRandomized Trial

Fengchun Wu, Min Xiu, Xiaoni Guan

November 3, 2025article en

Abstract

No abstract available for this paper.

Current NeuropharmacologyVol. 23

Peking University (CN), Beijing HuiLongGuan Hospital (CN), Guangzhou Medical University (CN)

Openalex Percentile: Top 61%

Schizophrenia research and treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-labelRandomized Trial — Fengchun Wu, Min Xiu, et al. · Current Neuropharmacology (2025) | TGRS Research Map | TGRS